• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

autoimmune

Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership to develop first in class therapies in autoimmune disease and immuno-oncology
February 7, 2019
Pharmaceutical News

Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership to develop first in class therapies

Pathios Therapeutics (“Pathios”), an innovative biotech company focused on the development of first in class therapies for autoimmune diseases and immuno-oncology and Sygnature Discovery (“Sygnature”), jointly announce a strategic partnership to accelerate Pathios’ drug discovery and development programmes. As part of the agreement, Pathios

More
Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership to develop first in class therapies in autoimmune disease and immuno-oncology
Pharmaceutical News

Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership to develop first in class therapies

February 7, 2019

Pathios Therapeutics (“Pathios”), an innovative biotech company focused on the development of first in class therapies for autoimmune diseases and

More
  • Meeting Global Demands for Viral Vector-based Vaccines
  • Croda and Botanical Solution Inc. (BSI) partner to fast-track sustainable vaccine adjuvant QS-21 production
  • Liquid Nitrogen Freezers Prove to be Game Changer for Pharma Industry
  • Breye Therapeutics Strengthens Management Team and Board
  • How Healthcare Professionals Benefit From Field Hospitals

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop